R&D News | pharmaphorum

News

HHS plans 10,000 more job cuts, taking target to 20,000

HHS Secretary Kennedy has said he intends to save $1.8bn per year, thanks to another wave of job cuts affecting the FDA, CDC, NIH, and CMS.

News

Alcon claims control of cell therapy firm Aurion

Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive.

News

Jean-François Toussaint, Sanofi's global head of vaccines R&D

FDA fast-tracks Sanofi's experimental chlamydia vaccine

Sanofi is preparing to start human testing of its chlamydia vaccine, now fast-tracked by the FDA, that it hopes will be the first to reach the market.

News

BIO rings alarm bells over Trump's pharma tariffs

US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.

News

J&J throws the gauntlet down to AZ with new survival data

New survival data from MARIPOSA for Johnson & Johnson's Rybrevant/Lazcluze combination in lung cancer could spell trouble for AstraZeneca.

News

Character Bio chief executive and co-founder Cheng Zhang

Character raises $93m for eye drugs, plus other financings

Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines.

HHS plans 10,000 more job cuts, taking target to 20,000

Alcon claims control of cell therapy firm Aurion

FDA fast-tracks Sanofi's experimental chlamydia vaccine

BIO rings alarm bells over Trump's pharma tariffs

J&J throws the gauntlet down to AZ with new survival data

Character raises $93m for eye drugs, plus other financings

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

News

Editor's Picks